Eagle Asset Management Inc. Purchases Shares of 24,632 Iradimed Corporation (NASDAQ:IRMD)

Eagle Asset Management Inc. acquired a new position in Iradimed Corporation (NASDAQ:IRMD - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 24,632 shares of the medical equipment provider's stock, valued at approximately $1,239,000. Eagle Asset Management Inc. owned 0.19% of Iradimed at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of IRMD. Sequoia Financial Advisors LLC bought a new position in shares of Iradimed in the second quarter worth $568,000. Allspring Global Investments Holdings LLC boosted its stake in Iradimed by 14.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 20,122 shares of the medical equipment provider's stock worth $1,012,000 after purchasing an additional 2,538 shares during the period. Albert D Mason Inc. bought a new position in Iradimed in the 3rd quarter worth about $737,000. Algert Global LLC grew its holdings in Iradimed by 84.1% during the 2nd quarter. Algert Global LLC now owns 26,774 shares of the medical equipment provider's stock valued at $1,176,000 after buying an additional 12,227 shares in the last quarter. Finally, Marshall Wace LLP bought a new stake in shares of Iradimed during the second quarter valued at about $463,000. 92.34% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Roth Mkm cut their price objective on shares of Iradimed from $65.00 to $60.00 and set a "buy" rating for the company in a research report on Friday, August 2nd.

Iradimed Stock Down 1.2 %

Shares of IRMD stock traded down $0.64 on Tuesday, reaching $52.75. The company's stock had a trading volume of 32,282 shares, compared to its average volume of 48,875. Iradimed Corporation has a 12-month low of $40.05 and a 12-month high of $57.95. The stock's 50 day simple moving average is $51.21 and its 200-day simple moving average is $46.89. The company has a market capitalization of $668.50 million, a P/E ratio of 36.13 and a beta of 0.79.

Iradimed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 25th. Stockholders of record on Friday, November 15th were issued a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 1.14%. The ex-dividend date was Friday, November 15th. Iradimed's payout ratio is 41.10%.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.